Evidence mapPaperPMID 38677235Full record

Trial reportJournal of psychosomatic research2024

FREE: A randomized controlled feasibility trial of a cognitive behavioral therapy and technology-assisted intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes.

Pamela Martyn-Nemeth, Jennifer Duffecy, Laurie Quinn, Chang Park, Sirimon Reutrakul, Dan Mihailescu, Minsun Park, Sue Penckofer

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of psychosomatic research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Pamela Martyn-NemethCollege of Nursing, Department of Biobehavioral Nursing Science, University of Illinois Chicago, Chicago, IL, United States of America. Electronic address: pmartyn@uic.edu.
Jennifer DuffecyDepartment of Psychiatry, College of Medicine, University of Illinois Chicago, Chicago, IL, United States of America.
Laurie QuinnCollege of Nursing, Department of Biobehavioral Nursing Science, University of Illinois Chicago, Chicago, IL, United States of America.
Chang ParkDepartment of Population Health Nursing Science, University of Illinois Chicago, Chicago, IL, United States of America.
Sirimon ReutrakulDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Illinois Chicago, Chicago, IL, United States of America.
Dan MihailescuDivision of Endocrinology, Cook County Health, Chicago, IL, United States of America.
Minsun ParkCollege of Nursing, Department of Biobehavioral Nursing Science, University of Illinois Chicago, Chicago, IL, United States of America.
Sue PenckoferLoyola University Chicago, School of Nursing, Chicago, IL, United States of America.
University of Illinois Chicago · USUniversity of Illinois Urbana-Champaign · USCook County Health and Hospitals System · USLoyola University Chicago · US

Funding

Research Design, Data, and Analytics CoreP30DK092949 · UNIVERSITY OF CHICAGO · 2025 to 2025
$660k
NCATS NIH HHS UL1 TR002003NIDDK NIH HHS P30 DK092949NIDDK NIH HHS R21 DK116146
6 · The paper itself

Abstract

objectiveThe purpose of this study was to test the preliminary effectiveness of a cognitive behavioral therapy intervention (Fear Reduction Efficacy Evaluation [FREE]) designed to reduce fear of hypoglycemia in young adults with type 1 diabetes. The primary outcome was fear of hypoglycemia, secondary outcomes were A1C, and glycemic variability.

methodsA randomized clinical trial was used to test an 8-week intervention (FREE) compared to an attention control (diabetes education) in 50 young adults with type 1 diabetes who experienced fear of hypoglycemia at baseline. All participants wore a continuous glucose monitor for the 8-week study period. Self-reported fear of hypoglycemia point-of-care A1C testing, continuous glucose monitor-derived glucose variability were measured at baseline, Week 8, and Week 12 (post-program).

resultsCompared to controls, those participating in the FREE intervention experienced a reduction in fear of hypoglycemia (SMD B = -8.52, p = 0.021), change in A1C (SMD B = 0.04, p = 0.841) and glycemic variability (glucose standard deviation SMD B = -2.5, p = 0.545) by the end of the intervention. This represented an 8.52% greater reduction in fear of hypoglycemia.

conclusionA cognitive behavioral therapy intervention (FREE) resulted in improvements in fear of hypoglycemia. CLINICALTRIALS: govNCT03549104.

Indexed as

Cognitive Behavioral TherapyDiabetes Mellitus, Type 1FearFeasibility StudiesHypoglycemiaAdolescentAdultBlood GlucoseBlood Glucose Self-MonitoringFemaleGlycated HemoglobinHumansMaleTreatment OutcomeYoung AdultBlood GlucoseGlycated HemoglobinFear of hypoglycemiaGlucose SDGlucose time-in-rangeGlycemic controlGlycemic variabilitySelf-management behaviorType 1 diabetes

Identifiers

PMID38677235
PMCPMC11162312
OpenAlexW4394981738

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.